Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADPT Adaptive Biotechnologies Corp

交易中 02-11 10:54:50 EST

14.94

-0.70

-4.51%

最高15.94	最低14.85	成交量36.34万
今开15.80	昨收15.64	日振幅6.97%
总市值22.97亿	流通市值17.53亿	总股本1.54亿
成交额557.48万	换手率0.31%	流通股本1.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADPT","market":"US","secType":"STK","nameCN":"Adaptive Biotechnologies Corp","latestPrice":14.935,"timestamp":1770825289688,"preClose":15.64,"halted":0,"volume":363366,"delay":0,"changeRate":-0.045076726342711,"floatShares":117369033,"shares":153779418,"eps":-0.392158,"marketStatus":"交易中","change":-0.705,"latestTime":"02-11 10:54:50 EST","open":15.8,"high":15.94,"low":14.85,"amount":5574785.517522,"amplitude":0.069693,"askPrice":14.95,"askSize":5,"bidPrice":14.93,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-0.392158,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":15.64,"preHourTrading":{"tag":"盘前","latestPrice":15.5947,"preClose":15.64,"latestTime":"09:09 EST","volume":47,"amount":734.054695,"timestamp":1770818984829,"change":-0.0453,"changeRate":-0.002896,"amplitude":0.008651},"postHourTrading":{"tag":"盘后","latestPrice":15.64,"preClose":15.64,"latestTime":"19:48 EST","volume":29120,"amount":455416.96,"timestamp":1770770907340,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.661288,"impliedVol":0.9303,"impliedVolPercentile":0.5976},"requestUrl":"/m/hq/s/ADPT/tweets","defaultTab":"tweets","newsList":[{"id":"1155755231","title":"异动解读 | 发布积极财务指引，Adaptive Biotechnologies盘后大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155755231","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155755231?lang=zh_cn&edition=full","pubTime":"2026-02-06 05:51","pubTimestamp":1770328279,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp（ADPT）今日盘后股价大幅上涨6.25%，引起了市场关注。消息面上，公司于盘后交易时段前发布了最新的财务指引。一方面，公司预计其微小残留病（MRD）业务板块在2024财年的全年营收将达到2.55亿美元至2.65亿美元，显示了该核心业务强劲的增长预期。另一方面，公司同时给出了全年运营开支（包含营收成本）的指引，预计将控制在3.5亿美元至3.6亿美元之间。市场分析认为，明确的营收增长前景与可控的成本预期相结合，增强了投资者对公司未来盈利能力的信心，从而推动了股价在盘后显著走高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"1152278122","title":"Adaptive Biotechnologies预计MRD业务全年营收将达2.55亿至2.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152278122","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152278122?lang=zh_cn&edition=full","pubTime":"2026-02-06 05:30","pubTimestamp":1770327035,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp（ADPT）公布其微小残留病（MRD）业务板块的全年营收指引。该公司预计，该业务在2024财年的总收入将介于2.55亿美元至2.65亿美元之间。这一预测反映了公司对MRD检测市场持续增长及自身商业化执行能力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"1163775372","title":"Adaptive Biotechnologies预计全年运营开支（含营收成本）介于3.5亿至3.6亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163775372","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163775372?lang=zh_cn&edition=full","pubTime":"2026-02-06 05:27","pubTimestamp":1770326846,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp（ADPT）发布最新财务指引，预计其全年运营开支——其中包含营收成本——将落在3.5亿美元至3.6亿美元的区间内。\n这一预测反映了公司在研发投入、商业拓展及日常运营方面的综合支出水平，为市场提供了明确的成本管控预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"1197379224","title":"财报前瞻 ｜Adaptive Biotechnologies Corp本季度营收预计增29.02%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1197379224","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197379224?lang=zh_cn&edition=full","pubTime":"2026-01-29 11:19","pubTimestamp":1769656774,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp将于2026年02月05日发布财报，市场关注本季度收入改善与利润修复节奏，以及主营微小残留病变服务的增长质量与盈利结构变化。- 一致预期显示，本季度Adaptive Biotechnologies Corp总收入预计为59,391,430美元，同比增29.02%；预计调整后每股收益为-0.18美元，同比改善29.27%；预计EBIT为-26,180,330美元，同比改善30.83%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Adaptive Biotechnologies Corp本季度营收预计增29.02%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT"],"gpt_icon":0},{"id":"1139304736","title":"Adaptive Biotechnologies Corp将保留Digital Biotechnologies近50%股权——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1139304736","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139304736?lang=zh_cn&edition=full","pubTime":"2025-12-30 21:03","pubTimestamp":1767099808,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件，Adaptive Biotechnologies Corp计划在Digital Biotechnologies中保留接近50%的所有权。这一股权结构安排凸显了该公司对数字生物技术领域长期战略布局的重视。文件显示，Adaptive Biotechnologies Corp通过此次股权保留，进一步巩固了其在创新生物技术赛道上的参与度。业内人士分析，这种股权架构既有利于保持战略灵活性，又能确保核心技术的协同发展。随着生物技术与数字化融合的加速，此类股权安排或将成为行业内的常见模式。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"1122966703","title":"自适应生物技术公司宣布在第67届ASH年会上展示近90篇关于Clonoseq® MRD检测的摘要，涵盖多种血癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1122966703","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122966703?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:31","pubTimestamp":1763987491,"startTime":"0","endTime":"0","summary":"自适应生物技术公司宣布在第67届ASH年会上展示近90篇关于Clonoseq® MRD检测的摘要，涵盖多种血癌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RRC","BK4585","ADPT","BK4213","BK4121","BK4588"],"gpt_icon":0},{"id":"1190020341","title":"异动解读 | 分析师上调目标价，Adaptive Biotechnologies股价盘中大涨6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190020341","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190020341?lang=zh_cn&edition=full","pubTime":"2025-11-06 23:31","pubTimestamp":1762443074,"startTime":"0","endTime":"0","summary":"生物科技公司Adaptive Biotechnologies今日盘中股价大涨6.01%，引发市场关注。消息面上，多家知名券商上调了Adaptive Biotechnologies的目标价。其中，TD Cowen将该公司的目标价从18美元上调至22美元，上调幅度达22%。分析师的积极态度表明他们对Adaptive Biotechnologies的未来发展前景持乐观看法，这可能是推动该公司股价上涨的主要原因。然而，投资者在做出投资决策时仍需谨慎，并密切关注公司的后续发展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"1139161748","title":"异动解读 | 分析师上调目标价，Adaptive Biotechnologies盘前大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139161748","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139161748?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:50","pubTimestamp":1762422640,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp在盘前交易中表现强劲，股价大涨5.23%，引发投资者关注。这一显著涨幅主要源于华尔街分析师对该公司前景的积极看法。据报道，投资银行TD Cowen上调了Adaptive Biotechnologies的目标股价，从此前的18美元提高至22美元，这一调整意味着分析师看好该公司未来的发展潜力。目标价的上调通常被视为对公司基本面和未来成长性的正面评估。对于Adaptive Biotechnologies而言，这可能反映了市场对其创新技术和产品管线的信心增强。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2575275907","title":"Adaptive Biotechnologies Corporation盘中异动 早盘快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575275907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575275907?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:42","pubTimestamp":1760535755,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时42分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅上涨5.01%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.05%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。消息层面，截至21时42分，《派杰投资维持Adaptive Biotechnologies买入评级，上调目标价至20美元》资讯为影响Adaptive Biotechnologies Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015214235a6bae97b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015214235a6bae97b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2518322001","title":"Adaptive Biotechnologies Corporation盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518322001?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:08","pubTimestamp":1741615711,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时08分，Adaptive Biotechnologies Corporation股票出现异动，股价快速下挫5.17%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3203.98%、694.50%、99.94%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为40.24%、32.14%、30.40%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220831a26a32b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220831a26a32b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2517165580","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517165580?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:34","pubTimestamp":1741271641,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时34分，Adaptive Biotechnologies Corporation股票出现异动，股价快速下挫5.53%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.64%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223401abeb786c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223401abeb786c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2517102949","title":"Adaptive Biotechnologies Corporation股价重挫14.53% 市值跌1.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517102949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517102949?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185062,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Adaptive Biotechnologies Corporation股票出现波动，股价急速下跌14.53%。截至发稿，该股报6.94美元/股，成交量142.435万股，换手率0.96%，振幅0.31%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.08%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2516722206","title":"Adaptive Biotechnologies Corporation盘中异动 大幅下跌5.01%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516722206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516722206?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098754,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Adaptive Biotechnologies Corporation股票出现异动，股价急速下跌5.01%。截至发稿，该股报7.69美元/股，成交量4.0044万股，换手率0.03%，振幅1.81%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.25%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042232349639449a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042232349639449a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2514859250","title":"Adaptive Biotechnologies Corporation盘中异动 早盘快速上涨5.11%报8.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859250?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:48","pubTimestamp":1740581323,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时48分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅上涨5.11%。截至发稿，该股报8.85美元/股，成交量9.5112万股，换手率0.06%，振幅4.16%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.28%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224843abddf16d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224843abddf16d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2514016839","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速下挫5.46%报7.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016839?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:32","pubTimestamp":1740497541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时32分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅下跌5.46%。截至发稿，该股报7.96美元/股，成交量25.6247万股，换手率0.17%，振幅6.15%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.78%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252332229630008a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252332229630008a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2512387165","title":"Adaptive Biotechnologies Corporation盘中异动 急速拉升5.04%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512387165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512387165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889180,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Adaptive Biotechnologies Corporation股票出现波动，股价急速上涨5.04%。截至发稿，该股报8.75美元/股，成交量4.7002万股，换手率0.03%，振幅3.00%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.11%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223301abd3af7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223301abd3af7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2511670403","title":"Adaptive Biotechnologies Corporation2024财年实现净利润-1.59亿美元，同比增加29.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511670403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511670403?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:00","pubTimestamp":1739635244,"startTime":"0","endTime":"0","summary":"2月16日，Adaptive Biotechnologies Corporation公布财报，公告显示公司2024财年净利润为-1.59亿美元，同比增加29.33%；其中营业收入为1.79亿美元，同比增加5.29%，每股基本收益为-1.08美元。从资产负债表来看，Adaptive Biotechnologies Corporation总负债3.37亿美元，其中短期债务10.24百万美元，资产负债比为1.60，流动比率为0.03。机构评级：截至2025年2月16日，当前有7家机构对Adaptive Biotechnologies Corporation目标价做出预测，其中目标均价为9.00美元，其中最低目标价为7.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000049a24729a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000049a24729a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT"],"gpt_icon":0},{"id":"1155355441","title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155355441","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155355441?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:16","pubTimestamp":1739474195,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp(ADPT)股价今日盘中大涨9.93%,引发市场关注。\n\n股价上涨主要受到机构评级目标价上调的利好消息驱动。投行Scotiabank维持对ADPT的评级为\"跑赢大盘\",并将目标价从10美元上调至12美元。此前,ADPT在生物技术行业内表现出较强的发展势头。\n\n作为一家专注于免疫驱动医学的生物科技公司,ADPT的临床诊断产品clonoSEQ已获FDA批准,可用于检测和监测多种血液肿瘤患者的最小残留病情。ADPT正着力将该产品推广至更广泛的淋巴癌适应症。公司在血液肿瘤诊断领域的创新有望为长期增长注入新动能。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2511951579","title":"Scotiabank：维持Adaptive Biotechnologies(ADPT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511951579","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511951579?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:11","pubTimestamp":1739473875,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Adaptive Biotechnologies(ADPT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14031148150865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"gpt_icon":0},{"id":"2511524052","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速上涨5.03%报7.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511524052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511524052?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:43","pubTimestamp":1739461435,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时43分，Adaptive Biotechnologies Corporation股票出现波动，股价大幅拉升5.03%。截至发稿，该股报7.93美元/股，成交量32.835万股，换手率0.22%，振幅7.35%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.50%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234356a244bb18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234356a244bb18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptivebiotech.com","stockEarnings":[{"period":"1week","weight":-0.1546},{"period":"1month","weight":-0.0076},{"period":"3month","weight":0.0786},{"period":"6month","weight":0.2105},{"period":"1year","weight":1.0365},{"period":"ytd","weight":-0.0369}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。公司正通过利用适应性免疫系统的固有生物学，向疾病的诊断和治疗转变，推进免疫驱动医学领域。该公司认为，适应性免疫系统是大自然对大多数疾病进行的最精细的诊断和治疗，但无法解码使医学界无法充分利用其能力。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司在动态临床免疫组学数据库中捕捉到这些见解，该数据库以计算生物学和机器学习为基础，用于开发和商业化公司正在为每位患者量身定制的临床产品和服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.006662},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.037098},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.104089},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.10078},{"month":5,"riseRate":0.5,"avgChangeRate":0.108472},{"month":6,"riseRate":0.833333,"avgChangeRate":0.100403},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.001043},{"month":8,"riseRate":0.571429,"avgChangeRate":0.074393},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.065733},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.030408},{"month":11,"riseRate":0.714286,"avgChangeRate":0.049327},{"month":12,"riseRate":0.714286,"avgChangeRate":0.032336}],"exchange":"NASDAQ","name":"Adaptive Biotechnologies Corp","nameEN":"Adaptive Biotechnologies Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptive Biotechnologies Corp,ADPT,Adaptive Biotechnologies Corp股票,Adaptive Biotechnologies Corp股票老虎,Adaptive Biotechnologies Corp股票老虎国际,Adaptive Biotechnologies Corp行情,Adaptive Biotechnologies Corp股票行情,Adaptive Biotechnologies Corp股价,Adaptive Biotechnologies Corp股市,Adaptive Biotechnologies Corp股票价格,Adaptive Biotechnologies Corp股票交易,Adaptive Biotechnologies Corp股票购买,Adaptive Biotechnologies Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}